Read more:

Tuesday, November 20, 2012

Global Heparin Market 2011-2015

Global Heparin Market 2011-2015

Global Heparin Market

TechNavio's analysts forecast the Global Heparin market to grow at a CAGR of 11.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in aging population. The Global Heparin market has also been witnessing the trend of an increase in RandD activities by the vendors to expand the focus area for heparin drugs and to capture the major share of the market. However, the patent expiry of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Heparin Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Heparin market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc., and Leo Pharma Inc.

The other vendors mentioned in the report are Bristol-Myers Squibb Co., Teva Pharmaceutical Industries Ltd., Wanbang Biochemical Pharmaceutical Co. Ltd., Celgene Corp., Mitsubishi Tanabe Pharma Corp., Baxter Healthcare Corp., and Shanghai No. 1 Biochemical Pharmaceutical Co. Ltd.

Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market. 

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size and Forecast
04.1 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Sanofi S.A.
Business Overview
SWOT Analysis
13.2 Pfizer Inc.
Business Overview
SWOT Analysis
13.3 GlaxoSmithKline plc
Business Overview
SWOT Analysis
13.4 Leo Pharma Inc.
Business Overview
SWOT Analysis
14. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Heparin Market 2011-2015 (US$ billion)
Exhibit 2: Global Heparin Market by Geographical Segmentation 2011
Exhibit 3: Global Heparin Market by Vendor Segmentation 2011
Exhibit 4: Business Segmentation of Sanofi S.A.
Exhibit 5: Business Segmentation of Pfizer Inc.
Exhibit 6: Business Segmentation of GlaxoSmithKline plc


No comments:

Post a Comment